[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DE2426913A1 - Malonic or succinic acid di(imido ester) prodn. - by reacting dicarboxylic acid dinitriles with anhydrous lower alcohols - Google Patents

Malonic or succinic acid di(imido ester) prodn. - by reacting dicarboxylic acid dinitriles with anhydrous lower alcohols

Info

Publication number
DE2426913A1
DE2426913A1 DE19742426913 DE2426913A DE2426913A1 DE 2426913 A1 DE2426913 A1 DE 2426913A1 DE 19742426913 DE19742426913 DE 19742426913 DE 2426913 A DE2426913 A DE 2426913A DE 2426913 A1 DE2426913 A1 DE 2426913A1
Authority
DE
Germany
Prior art keywords
prodn
dmd
acid
diimidates
diimidate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19742426913
Other languages
German (de)
Inventor
Bent Prof Dr Havsteen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ferring Arzneimittel GmbH
Original Assignee
Ferring Arzneimittel GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Arzneimittel GmbH filed Critical Ferring Arzneimittel GmbH
Priority to DE19742426913 priority Critical patent/DE2426913A1/en
Publication of DE2426913A1 publication Critical patent/DE2426913A1/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/006General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length of peptides containing derivatised side chain amino acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)

Abstract

are produced by reacting dicarboxylic acid dinitriles with a 3-4C chain-length with anhydrous lower alcohols in the presence of gaseous HCl at ca 0 degree C. Dimethyl malonic acid diimidate (DMD) and dimethyl succinic acid diimidate (DSD) are claimed as new cpds. The use of diimidates for the prodn. of peptide dimers with strengthened structure and enhanced biological activity is claimed. The prods. are bifunctional reagents which react with proteins under mild conditions to yield stabilised protein derivs. The diimidates can be produced in high yields, and the process for their prodn. can readily be automated. DMD and DSD react rapidly with proteins and with high selectivity. DMD and protein derivs. formed with it are highly water-soluble.

Description

Verfahren zu ihrer Herstellung und Anwendung in der Peptidchemie Die Erfindung betrifft die Dicarbonsäure-Diiinidate DMD und DSD, Verfahren zu ihrer Herstellung und Anwendung in der Peptidchemie.Process for their preparation and application in peptide chemistry The invention relates to the dicarboxylic acid diinidates DMD and DSD, processes for their Manufacture and application in peptide chemistry.

Es ist erwünscht bifunktionale Reagenzien, die unter milden Bedingungen zur Herstellung von Proteinderivaten verwendet werden können, zur Verfügung zu haben. Dabei ist es jedoch erforderlich, daß die Länge der Kohlenstoffketten, die eingefahrt werden, 3 -4 Kohlenstoffatome nicht übersteigt, da die Anwendung längerkettiger Verbindungen zur Herstellung von Peptidderivaten nicht zur Gewinnung stabilisierter Moleküle führen würde.It is desirable to use bifunctional reagents that operate under mild conditions for the production of protein derivatives can be used. However, it is necessary that the length of the carbon chains that are retracted does not exceed 3 -4 carbon atoms, since the application is longer-chain Compounds for the production of peptide derivatives not for the production of stabilized ones Molecules would lead.

Es ist bekannt zur Abwandlung von Protein-Aminogruppen Imidoester als Gruppen-spezifische Reagenzien zu verwenden, wobei Amidingruppen entstehen (vgl. Hunter, M.J. and Ludwig, M.L., J. Am. Chem. Soc. 84 (1962) 3491 - 3504). Nach dieser Arbeit wurden jedoch nur Monoimidate - wie salz saures Methyl-Benzimidat und Methyl-Acetimidat - hergestellt und verwendet.It is known that imidoesters are used to modify protein amino groups to be used as group-specific reagents, resulting in amidine groups (cf. Hunter, M.J. and Ludwig, M.L., J. Am. Chem. Soc. 84 (1962) 3491-3504). After this However, only monoimidates - such as hydrochloric acid methyl benzimidate and methyl acetimidate - were used - manufactured and used.

Der Erfindung liegt die Aufgabe zugrunde bifunktionale Reagenzien zu gewinnen, die zur Herstellung stabilisierter Proteinderivate unter milden Bedingungen geeignet sind.The invention is based on the object of bifunctional reagents to win the production of stabilized protein derivatives under mild conditions are suitable.

Diese Aufgabe wird erfindungsgemäß dadurch gelöst, daß man Dicarbonsäuredinitril mit einer Kohlenstoff-Kettenlänge von 3 - 4 mit wasserfreien kurzkettigen Alkoholen in Gegenwart von gasförmiger Salzsäure bei etwa Oo umsetzt.According to the invention, this object is achieved by using dicarboxylic acid dinitrile with a carbon chain length of 3 - 4 with anhydrous short-chain Reacts alcohols in the presence of gaseous hydrochloric acid at about Oo.

Nach diesem Verfahren wurden Malonsäuredinitril und Bernsteinsäuredinitril mit Methanol zu Dimethylmalonsäure-Diimidat und Dimethylbernsteinsäure-Diimidat - welche im folgenden mit DMD und DSD bezeichnet werden - umgesetzt.According to this procedure, malononitrile and succinic acid dinitrile were made with methanol to dimethylmalonic acid diimidate and dimethylsuccinic acid diimidate - which are referred to below as DMD and DSD - implemented.

Die nach der Erfindung erzielten Vorteile bestehen insbesondere darin, daß die Diimidate in großer Ausbeute zugänglich sind und sich das Verfahren zu ihrer Herstellung leicht automatisieren läßtO Die Anwendung der neuen Verbindungen DMD und DSD zur Herstellung neuer Proteinderivate hat den Vorteil, daß die Reaktion schnell und vollständig abläuft und eine hohe Selektivität besitzt. Dies wird auf die Kürze der eingeführten Kohlenstoffbrücke zurückgeführt, die besonders stabil und genau definiert ist. Sie ist auch ausreichend stabil für proteolytische Verfahren. Das Reagenz DMD und das gebildete Proteinderivat sind ferner stark wasserlöslich, und daher eignen sie sich für weitere Reaktionen und für optische Untersuchungen. Die Haltbarkeit der erfindungsgemäßen Diimidate entspricht etwa derjenigen des damit hergestellten Chymotrypsin-Dimers.The advantages achieved according to the invention are in particular: that the diimidates are accessible in large yield and the process to their Manufacturing can be easily automated. The application of the new DMD compounds and DSD for the production of new protein derivatives has the advantage that the reaction runs quickly and completely and has a high selectivity. This is going on the brevity of the carbon bridge introduced, which is particularly stable and is well defined. It is also sufficiently stable for proteolytic procedures. The reagent DMD and the protein derivative formed are also highly soluble in water, and therefore they are suitable for further reactions and for optical investigations. The shelf life of the diimidates according to the invention corresponds roughly to that of the diimidates according to the invention produced chymotrypsin dimer.

Es ist auch wahrscheinlich, daß die Reagenzien DMD und DSD benutzt werden können, um andere Mitglieder der Klasse von Enzymen zu aktivieren, zu der Chymotrypsin gehört.It is also likely that the reagents used DMD and DSD can be used to activate other members of the class of enzymes to which Chymotrypsin heard.

Beispiel Zu Malonsäuredinitril wird wasserfreies Methanol bei 0° hinzugefügt. Es wird langsam gasförmiger Chlorwasserstoff eingeleitet, sodaß die Temperatur wegen der stark exothermen Reaktion nicht ansteigt. Das Reaktionsprodukt DMD kristallisiert im Reaktionsgefäß aus und wird aus einer Mischung von Äthanol und Äther umkristallisiert. Ausbeute bis zu 80%; Fp = 980. Die Synthese wird unter wasserfreien Bedingungen ausgeführt, da das Produkt in Wasser langsam hydrolysiert und Nebenprodukte entstehen können, die schwer zu entfernen sind. Example Anhydrous methanol becomes malononitrile at 0 ° added. Gaseous hydrogen chloride is slowly passed in, so that the Temperature does not rise because of the strongly exothermic reaction. The reaction product DMD crystallizes out in the reaction vessel and is made from a mixture of ethanol and ether recrystallized. Yield up to 80%; M.p. = 980. The synthesis will under run anhydrous conditions as the product hydrolyzes slowly in water and by-products that are difficult to remove can arise.

Anwendung von DMD in der Peptidchemie DMD kann benutzt werden, um zwei Enzymmoleküle Chymotrypsin an ihren aktiven Stellen miteinander zu verbinden : es reagiert mit Methionyl- und Histidyl-Seitenketten, wobei covalente Brücken gebildet werden. Durch die Umsetzung von DMD mit Chymotrypsin wird 0 ) die akt-ive Stelle des Chymotrypsinmoleküls stabilisiert, da die Brücke kurz und fest ist, 2o) die spezifische esterolytische Aktivität des Enzyms um maximal das 500- bis 1000-fache erhöht, 3.) die Aktivität gegenüber kleinen spezifischen Amiden auf etwa*10°S des Ausgangswertes herabgesetzt und 4.) die frühere augenblickliche und irreversible Hemmung des Enzyms durch Diisopropylfluorphosphat zu einer schwachen konkurrierenden Hemmung verringert. Aus diesem Grunde können andere für dieses Gift empfindliche Enzyme in Gegenwart des modifizierten Chymotlypsin-dimers vollständig inaktiviert werden ohne Schädigung des letzteren. Die konkurrierende Hemmung kann durch Dialyse aufgehoben werden. Application of DMD in peptide chemistry DMD can be used to to connect two enzyme molecules chymotrypsin to each other at their active sites : it reacts with methionyl and histidyl side chains, with covalent bridges are formed. By implementing DMD with chymotrypsin, 0) becomes the active Location of the chymotrypsin molecule stabilized because the bridge is short and firm, 2o) the specific esterolytic activity of the enzyme by a maximum of 500 to 1000 times increased, 3.) the activity towards small specific amides to about * 10 ° S des Initial value reduced and 4.) the earlier instantaneous and irreversible Inhibition of the enzyme by diisopropyl fluorophosphate to a weak competitive Inhibition decreased. Because of this, others may be sensitive to this poison Enzymes completely inactivated in the presence of the modified chymotlypsin dimer will be without harming the latter. The competing inhibition can be through dialysis To get picked up.

Dieses Verfahren schärft die Spezifität durch begrenzte Proteolyse, was sowohl bei der Medizinischen wie auch der wissenschaftlichen Aewend.ng exstrebenswert ist.This procedure sharpens the specificity through limited proteolysis, something that is desirable in both medical and scientific research is.

PatentallsprüchePatent claims

Claims (1)

Patentanspr-üche : Verfahren zur Herstellung von Diimidaten, dadurch gekennzeichnet, daß man Dicarbonsäure-Dinitrile mit einer Kohlenstoff-Kettealänge von 3 - 4 mit wasserfreien kurzkettigen Alkoholen in Gegenwart von gasförmiger Salzsäure bei etwa 0° umsetzt. Claims: Process for the production of diimidates, thereby characterized in that one dicarboxylic acid dinitriles with a carbon chain length of 3 - 4 with anhydrous short-chain alcohols in the presence of gaseous hydrochloric acid converts at about 0 °. 2.) Verfahren nach Anspruch 1, dadurch gekennzeichnet, daß man Malonsäuredinitril mit Methanol umsetzt 3 o) Dimethylmalonsäure-Diimidat.2.) Process according to claim 1, characterized in that malononitrile reacts with methanol 3 o) dimethylmalonic acid diimidate. 4.) Dimethylbernsteinsäure-Diimidat.4.) Dimethylsuccinic acid diimidate. 5.) Anwendung der Diimidate zur Herstellung von Peptiddimeren mit verstärkter Struktur und erhöhter biologischer Aktivität.5.) Use of the diimidates for the production of peptide dimers with enhanced structure and increased biological activity.
DE19742426913 1974-06-04 1974-06-04 Malonic or succinic acid di(imido ester) prodn. - by reacting dicarboxylic acid dinitriles with anhydrous lower alcohols Pending DE2426913A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
DE19742426913 DE2426913A1 (en) 1974-06-04 1974-06-04 Malonic or succinic acid di(imido ester) prodn. - by reacting dicarboxylic acid dinitriles with anhydrous lower alcohols

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19742426913 DE2426913A1 (en) 1974-06-04 1974-06-04 Malonic or succinic acid di(imido ester) prodn. - by reacting dicarboxylic acid dinitriles with anhydrous lower alcohols

Publications (1)

Publication Number Publication Date
DE2426913A1 true DE2426913A1 (en) 1975-12-11

Family

ID=5917265

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19742426913 Pending DE2426913A1 (en) 1974-06-04 1974-06-04 Malonic or succinic acid di(imido ester) prodn. - by reacting dicarboxylic acid dinitriles with anhydrous lower alcohols

Country Status (1)

Country Link
DE (1) DE2426913A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053498A (en) * 1976-07-30 1977-10-11 The United States Of America As Represented By The Secretary Of The Air Force Perfluoroalkylene ether-imidate and -thioimidate esters
US4288383A (en) * 1979-08-14 1981-09-08 E. I. Du Pont De Nemours And Company Propenimidates, their preparation and rearrangement to pyrimidines
US4301087A (en) * 1980-08-18 1981-11-17 Standard Oil Company Manufacture of carbamates from cyanogen
US4824949A (en) * 1986-12-16 1989-04-25 Hoechst Aktiengesellschaft Process for the preparation of pyrimidines
US4831138A (en) * 1986-12-16 1989-05-16 Hoechst Aktiengesellschaft Process for the preparation of aminopyrimidines
US5070201A (en) * 1989-10-24 1991-12-03 Hoechst Ag Process for the preparation of aminopyrimidines
US5208337A (en) * 1990-09-15 1993-05-04 Hoechst Aktiengesellschaft Process for the preparation of aminopyrimidines
US7141670B2 (en) 2001-10-15 2006-11-28 Lonza Ltd. Process for the preparation of 1-(pyrimidin-2-yl)propan-2-ones

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053498A (en) * 1976-07-30 1977-10-11 The United States Of America As Represented By The Secretary Of The Air Force Perfluoroalkylene ether-imidate and -thioimidate esters
US4288383A (en) * 1979-08-14 1981-09-08 E. I. Du Pont De Nemours And Company Propenimidates, their preparation and rearrangement to pyrimidines
US4301087A (en) * 1980-08-18 1981-11-17 Standard Oil Company Manufacture of carbamates from cyanogen
US4824949A (en) * 1986-12-16 1989-04-25 Hoechst Aktiengesellschaft Process for the preparation of pyrimidines
US4831138A (en) * 1986-12-16 1989-05-16 Hoechst Aktiengesellschaft Process for the preparation of aminopyrimidines
US5070201A (en) * 1989-10-24 1991-12-03 Hoechst Ag Process for the preparation of aminopyrimidines
US5208337A (en) * 1990-09-15 1993-05-04 Hoechst Aktiengesellschaft Process for the preparation of aminopyrimidines
US7141670B2 (en) 2001-10-15 2006-11-28 Lonza Ltd. Process for the preparation of 1-(pyrimidin-2-yl)propan-2-ones

Similar Documents

Publication Publication Date Title
JPH04145099A (en) Polypeptide derivative having gip-like activity and use thereof
DE2426913A1 (en) Malonic or succinic acid di(imido ester) prodn. - by reacting dicarboxylic acid dinitriles with anhydrous lower alcohols
DE69615022T2 (en) METHOD FOR PRODUCING 3- (METHYLTHIO) PROPANAL AND 2-HYDROXY-4- (METHYLTHIO) BUTANIC ACID NITRILE
DE68902219T2 (en) MERCAPTOALKYL ACETOACETATE, THE USE THEREOF AND A METHOD FOR THE PRODUCTION THEREOF.
DE60026708T2 (en) METHOD FOR THE PROTECTION OF PROTECTED THIOLS
DE1804540A1 (en) Process for the production of sarcosine nitrile
DE2455623C3 (en) Process for the preparation of N-acylaminocarboxylic acid polyethyleneglycol esters
DE3789558T2 (en) Manufacture of organic phosphinites.
DE194040C (en)
DE69003559T2 (en) Process for the preparation of 2,4,5-trifluorobenzenic acid.
EP0074072B2 (en) Process for the continuous production of quinoline salts
DE1063146B (en) Process for the production of carbamic acid esters
Vančíková et al. Aging of connective tissue. Solubilisation of collagen from animals varying in age and species by reagents capable of splitting aldimine bonds
US3019253A (en) Acetyl-4-trifluoromethyl salicylic acid
Emmons et al. The Aminolysis of N-Nitrotoluenesulfonamides1
DE968545C (en) Process for the preparation of bases of the 1-phenyl-2-aminopropane series
EP0336185B1 (en) 1-(n-formylamino)-2,4-dicyanobutane and a process for its preparation
EP0348780A2 (en) Process for producing proteins
DE2152370A1 (en) METHOD OF PRODUCING AN ANGULAR CLAMP ON (1-ETHYL-PYRROLIDINYL2) -METHYL ANGLE CLAMP TO -2-METHOXY5-SULFAMOYL-BENZAMIDE
DE222809C (en)
US797792A (en) Alkyl-oxy-acetyl urea and process of making same.
DE2247347A1 (en) PROCESS FOR PREPARING PURE 1-AMINO-4-NITROANTHRACHINONE-2-CARBONIC ACID
DE955599C (en) Process for the preparation of 2-oxynaphthalene-3-carboxylic acid
DE886906C (en) Process for the preparation of methylene-bis-chloropropionic acid amide
DE753132C (en) Process for the production of substituted proteins (chemically labeled antigens)

Legal Events

Date Code Title Description
OHN Withdrawal